Company
IN8BIO, INC. (INAB)
Standardized SEC financial data for IN8BIO, INC. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001740279 · NASDAQ · Biological Products, (No Diagnostic Substances).
Return on equity
-70.5%
Free cash flow
-$12.7M
Current ratio
8.82×
EPS (diluted)
$-4.44
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| R&D expense | $5.4M | $7.3M | $14.1M | $16.8M | $17.0M | $10.2M |
| SG&A expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $18.1M | $37.3M | $18.4M | $21.5M | $11.4M | $27.3M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$7.1M | -$13.5M | -$24.1M | -$23.3M | -$24.1M | -$12.7M |
| Investing cash flow |
Get INAB data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/INAB/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/INAB/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"